Bioassays are enhancedd by technology providing complete solution for evaluating cell cultures, primary cells and blood cells with easy-to-use instruments, reagent kits and software
Guava Technologies has announced a series of methods enabling researchers to establish a baseline for functional performance of cell cultures prior to running bioassays.
Its CellHeath Profiling technology is said to provide the ideal, complete solution for evaluating cell cultures, primary cells and blood cells with easy-to-use instruments, reagent kits and software.
Knowing a cell population's ability to function, and renew itself before performing bioassays can mean the difference between valid assay results and wasted reagents, lost time, and discarded data.
Profiling key cellular indicators, such as apoptotic fraction and stage of apoptosis, viability, cell cycle, cell counts, transfection efficiency, or target expression levels - Guava's CellHeath Profiling technology allows labs to establish uniform standards of cellular performance.
Guava says the hallmarks of its systems are their compact sizes and convenient, comprehensive menu of assays.
With footprints as small as one square foot (30x30cm), they occupy a fraction of the bench space of traditional cytometers.
CellHeath Profiling systems are hands-on, affordable, and easy-to-use with less than a day's training.
Assays require only micro-volumes of cells and reagents, and generate minimal waste.
Whether determining screen/no screen criteria for HTS, monitoring and optimising bioreactor conditions, preparing cell cultures for therapy, or reducing variability in Elispot assays, Guava sayus CellHeath Profiling systems can increase confidence in bioassay outcomes.
